Innovation Pharmaceuticals Inc.
Innovation Pharmaceuticals Inc. (IPIX) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · IPIX · as of Jun 9, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Innovation Pharmaceuticals Inc. insiders have shown mixed buying and selling activity over the past 12 Months.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
IPIX insider buying and selling by quarter
IPIX insider selling · IPIX insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Recent insider transactions
IPIX executive sell shares · IPIX board member insider trading · IPIX insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jun 30, 2016 | Bertolino Arthur Peter Pres. & Chief Medical Officer | Award | 1,066,667 | — | Form 4 |
| Nov 30, 2015 | Menon Krishna President and CSO · Director | Other | 6,000,000 | — | Form 4 |
| Aug 28, 2014 | Menon Krishna President, CSO · Director | Other | 10,000,000 | — | Form 4 |
| Aug 3, 2004 | WILDS DAVID M Director | Sale | 2,820 | $25K | Form 4 |
| Aug 4, 2004 | WILDS DAVID M Director | Sale | 9,983 | $90K | Form 4 |
| Jul 26, 2004 | WILDS DAVID M Director | Other | 46,250 | $405K | Form 4 |
| Jun 17, 2004 | FIRST AVENUE PARTNERS L P /TN/ 10 percent owner | Other | 78,932 | $171K | Form 4 |
| Jun 17, 2004 | FIRST AVENUE PARTNERS L P /TN/ 10 percent owner | Sale | 48,809 | $732K | Form 4 |
| Jun 16, 2004 | FIRST AVENUE PARTNERS L P /TN/ 10 percent owner | Sale | 1,404 | $21K | Form 4 |
| Jun 9, 2004 | WILDS DAVID M Director | Other | 75,076 | $163K | Form 4 |
| Jun 9, 2004 | WILDS DAVID M Director | Sale | 65,302 | $887K | Form 4 |
| Jun 3, 2004 | WILDS DAVID M Director | Other | 148,605 | $322K | Form 4 |
Bertolino Arthur Peter
Pres. & Chief Medical Officer
Date
Jun 30
Shares
1,066,667
Price
—
Value
—
Menon Krishna
President and CSO · Director
Date
Nov 30
Shares
6,000,000
Price
—
Value
—
Menon Krishna
President, CSO · Director
Date
Aug 28
Shares
10,000,000
Price
—
Value
—
FIRST AVENUE PARTNERS L P /TN/
10 percent owner
Date
Jun 17
Shares
78,932
Price
$2.17
Value
$171K
FIRST AVENUE PARTNERS L P /TN/
10 percent owner
Date
Jun 17
Shares
48,809
Price
$15.00
Value
$732K
FIRST AVENUE PARTNERS L P /TN/
10 percent owner
Date
Jun 16
Shares
1,404
Price
$15.00
Value
$21K
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About IPIX insider trading
IPIX insider trades
Innovation Pharmaceuticals Inc. (IPIX) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including IPIX. Over the past 12 months, 0 insiders have filed transactions with the SEC. IPIX insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Innovation Pharmaceuticals Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
IPIX insider trading · 5 questionsThe insiders of Innovation Pharmaceuticals Inc. (IPIX) include executives and directors such as IPIX, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026